38 Results

People

  1. Bertino
    Bertino
  2. Lee
    Lee
  3. Majumdar
    Majumdar
  4. Saltz
    Saltz
  5. Corless
    Corless
  6. Finn
    Finn
  7. Fong
    Fong
  8. Gardner
    Gardner
  9. Hudis
    Hudis
  10. Larson
    Larson

Groups

  1. GSK Faculty (12)
  2. Department of Medicine (11)
  3. Molecular Pharmacology and Chemistry Program Faculty (10)
  4. Sloan Kettering Institute Faculty (10)
  5. Solid Tumor Oncology Division (8)
  6. Radiology, Department of (6)
  7. Sloan Kettering Institute Postdocs (6)
  8. Surgery (6)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  10. Breast Medicine Service (4)
  1. "prodrug"
Formats
  1. Journal Article (37)
  2. Research Letter (1)
Groups
  1. GSK Faculty (12)
  2. Department of Medicine (11)
  3. Molecular Pharmacology and Chemistry Program Faculty (10)
  4. Sloan Kettering Institute Faculty (10)
  5. Solid Tumor Oncology Division (8)
  6. Radiology, Department of (6)

More Groups

People
  1. Joseph Bertino (4)
  2. Jonghan Lee (3)
  3. Leonard Saltz (3)
  4. Susruta Majumdar (3)
  5. Broderick Corless (2)
  6. Clifford Hudis (2)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (2)
  4. 2022 (1)
  5. 2020 (1)
  6. 2019 (1)

More Years

Publications
  1. Clinical Cancer Research (3)
  2. Journal of Nuclear Medicine (3)
  3. Journal of Clinical Oncology (2)
  4. Molecular Cancer Therapeutics (2)
  5. Molecules (2)
  6. ACS Medicinal Chemistry Letters (1)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. Elsevier Inc. (4)
  3. Nature Publishing Group (4)
  4. Society of Nuclear Medicine (3)
  5. American Chemical Society (2)
  6. American Society of Clinical Oncology (2)

More Publishers

Results (38)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pharmacokinetics, biodistribution, and antitumor efficacy of a human glandular kallikrein 2 (hK2)-activated thapsigargin prodrug
    Journal Article

    Janssen, S.; Rosen, D. M.; Ricklis, R. M.; Dionne, C. A.; Lilja, H.; Christensen, S. B.; Isaacs, J. T.; Denmeade, S. R.
    Prostate (2006)

    Fulltext@MSK | Save
  • Fifth International Conference on Ovarian Cancer: Challenges and opportunities
    Journal Article

    Sood, A. K.; Abu-Rustum, N. R.; Barakat, R. R.; Bodurka, D. C.; Brown, J.; Donato, M. L.; Poynor, E. A.; Wolf, J. K.; Gershenson, D. M.
    Gynecologic Oncology (2005)

    Fulltext@MSK | Save
  • Improving rectal cancer outcomes with chemotherapy
    Journal Article

    Schrag, D.
    Seminars in Colon and Rectal Surgery (2005)

    Fulltext@MSK | Save
  • Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer
    Journal Article

    Kavanagh, J. J.; Gershenson, D. M.; Choi, H.; Lewis, L.; Patel, K.; Brown, G. L.; Garcia, A.; Spriggs, D. R.
    International Journal of Gynecological Cancer (2005)

    Fulltext@MSK | Save
  • Specific tumour localisation of a huA33 antibody - Carboxypeptidase A conjugate and activation of methotrexate-phenylalanine
    Journal Article

    Deckert, P. M.; Bornmann, W. G.; Ritter, G.; Williams, C.; Franke, J.; Keilholz, U.; Thiel, E.; Old, L. J.; Bertino, J. R.; Welt, S.
    International Journal of Oncology (2004)

    Fulltext@MSK | Save
  • Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer
    Journal Article

    Janssen, S.; Jakobsen, C. M.; Rosen, D. M.; Ricklis, R. M.; Reineke, U.; Christensen, S. B.; Lilja, H.; Denmeade, S. R.
    Molecular Cancer Therapeutics (2004)

    Fulltext@MSK | Save
  • The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies
    Journal Article

    Hamstra, D. A.; Lee, K. C.; Tychewicz, J. M.; Schepkin, V. D.; Moffat, B. A.; Chen, M.; Dornfeld, K. J.; Lawrence, T. S.; Chenevert, T. L.; Ross, B. D.; more...
    Molecular Therapy (2004)

    Fulltext@MSK | Save
  • Activation of a camptothecin prodrug by specific carboxylesterases as predicted by quantitative structure-activity relationship and molecular docking studies
    Journal Article

    Yoon, K. J. P.; Krull, E. J.; Morton, C. L.; Bornmann, W. G.; Lee, R. E.; Potter, P. M.; Danks, M. K.
    Molecular Cancer Therapeutics (2003)

    Fulltext@MSK | Save
  • (124)I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice
    Journal Article

    Sundaresan, G.; Yazaki, P. J.; Shively, J. E.; Finn, R. D.; Larson, S. M.; Raubitschek, A. A.; Williams, L. E.; Chatziioannou, A. F.; Gambhir, S. S.; Wu, A. M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • A33scFV-cytosine deaminase: A recombinant protein construct for antibody-directed enzyme-prodrug therapy
    Journal Article

    Deckert, P. M.; Renner, C.; Cohen, L. S.; Jungbluth, A.; Ritter, G.; Bertino, J. R.; Old, L. J.; Welt, S.
    British Journal of Cancer (2003)

    Fulltext@MSK | Save